INNATE PHARMA SA-SPONS ADR (IPHA) Stock Technical Analysis
USA - NASDAQ:IPHA - US45781K2042 - ADR
Overall IPHA gets a technical rating of 9 out of 10. Both in the recent history as in the last year, IPHA has proven to be a steady performer, scoring decent points in every aspect analyzed.
Although IPHA has an excellent technical rating, it does not offer a high quality setup at the moment. Prices have been extended to the upside lately. For a nice entry it is better to wait for a consolidation.
More info and screens
1.65
When analyzing the support we can see 5 important areas.
- A support zone ranging from 2.14 to 2.15. This zone is formed by a combination of multiple trend lines and important moving averages in the daily time frame.
- A support zone ranging from 2.05 to 2.10. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- A support zone ranging from 1.81 to 1.82. This zone is formed by a combination of multiple trend lines in multiple time frames.
- Support @1.72 from a horizontal line in the daily time frame.
- Support @1.67 from a horizontal line in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for IPHA is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for IPHA is up. |
| ChartMill Relative Strength | 76.7 | POSITIVE | IPHA has a high relative strength, it outperformed 76.7% off all stocks on the market. |
| Simple Moving Average/SMA (20) | UP | POSITIVE | The current price of IPHA is above the rising SMA(20). |
| Simple Moving Average/SMA (50) | UP | POSITIVE | The current price of IPHA is above the rising SMA(50). |
| Simple Moving Average/SMA (200) | UP | POSITIVE | The current price of IPHA is above the rising SMA(200). |
| Relative Strength Index/RSI (14) | 72.79 | OVERBOUGHT | The high RSI value suggests IPHA may be overbought. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.03 | POSITIVE | The MACD value suggests IPHA has a positive trend. |
| Stochastics (14,3) | 81.29 | OVERBOUGHT | The high Stochastics value suggests IPHA may be overbought. |
| Average True Range in percent/ATR (20) | 4.5 | MEDIUM VOLATILITY | The ATR as a percentage value for IPHA suggests some volalility. |
| Average Directional Index/ADX (14) | 21.66 | NEUTRAL | The ADX value for IPHA suggests a possible start of a new trend. |
NASDAQ:IPHA (10/27/2025, 8:00:03 PM)
2.38
+0.18 (+8.18%)
INNATE PHARMA SA-SPONS ADR / IPHA FAQ
What is the ChartMill technical rating of INNATE PHARMA SA-SPONS ADR (IPHA) stock?
ChartMill assigns a technical rating of 9 / 10 to IPHA.
What is the trend direction for IPHA stock?
The current trend direction for INNATE PHARMA SA-SPONS ADR (IPHA) is Bullish.
What is the RSI signal for IPHA stock?
INNATE PHARMA SA-SPONS ADR (IPHA) has an RSI value of 72.7901. This indicates that the stock is currently overbought.
What is the short term momentum for INNATE PHARMA SA-SPONS ADR (IPHA) stock?
The short term momentum for INNATE PHARMA SA-SPONS ADR (IPHA) is positive.
What is the support and resistance level for IPHA stock?
INNATE PHARMA SA-SPONS ADR (IPHA) has a support level at 2.15. Check the full technical report for our detailed analysis of IPHA support and resistance levels.